Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab continuation in moderate to severe chronic plaque psoriasis
NCT00195676Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2004
- Primary completion
- Oct 2009
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in plaque psoriasis, sponsored by Abbott Laboratories. Primary endpoint: Percentage of Participants With a Physician's Global Assessment of Clear or Minimal. Started May 2004; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00195676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195676.